氧化 ангиотензин II 作为细胞信号传递的媒介?
Fariha E Bablu1, Tadahisa Teramoto2, Yuichiro J Suzuki1
1Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC, 20057, USA.
Free radical biology & medicine
|October 23, 2025
概括
反应性氧物种 (ROS) 和血管素II (Ang II) 可以直接氧化,形成新型. 这提出了新的氧化还原信号通路和翻译后氨基酸修饰机制.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞信号传输 细胞信号传输
背景情况:
- 反应性氧物种 (ROS) 和血管素II (Ang II) 都与疾病的发病有关.
- ангиотензин II 激活 NADPH 氧化酶,产生 ROS,但其直接氧化尚未研究.
- 蛋白质碳化可以将氨酸 (Arg) 和氨酸 (Pro) 残留物转化为谷氨酸半化物,然后是谷氨酸 (Glu).
研究的目的:
- 通过反应性氧物种 (ROS) 对 ангиотензин II (Ang II) 的直接氧化进行研究.
- 在质结构中探索翻译后氨基酸修饰的新机制.
- 提出新的氧化还原信号通路,由氧化AngII介导.
主要方法:
- 对Ang II结构和已知的氧化修饰途径的假设驱动分析.
- 关于ROS,AngII和氨基酸转换的现有文献的综述.
- 在Ang II上潜在的氧化变化的理论建模.
主要成果:
- 含有Arg和Pro残留物的 ангиотензинII (AngII) 被假设通过ROS直接氧化.
- 氧化可以通过谷氨酸半化物将Arg或Pro残留物转化为Pro或Glu.
- 氧化Ang II可能具有独特的生物活动,可能触发细胞信号.
结论:
- ангиотензин II (Ang II) 可能会被活性氧物种 (ROS) 直接氧化,从而导致变化的序列.
- 这种氧化代表了一种新的氧化还原信号和翻译后修改机制.
- 氧化Ang II为了解疾病中的细胞信号提供了新的可能性.
更多相关视频
07:21Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
39.0K
09:51Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
10.1K
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K